Cardiovascular disease in rheumatoid arthritis: Current perspectives on assessing and mitigating risk in clinical practice

Best Practice and Research: Clinical Rheumatology

Volumn 29, Issue 4-5, 2015, Pages 597-613

  Giles, Jon T ^a  

^a Physicians and Surgeons Building ^*  (United States)

Author keywords

Atherosclerosis; Cardiovascular imaging; Prediction; Rheumatoid arthritis; Risk algorithms; Screening

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; DISEASE MODIFYING ANTIRHEUMATIC DRUG; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ANTIRHEUMATIC AGENT;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CLINICAL PRACTICE; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE ACTIVITY; HUMAN; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; PATIENT RISK; PRACTICE GUIDELINE; PREDICTION; PRIMARY PREVENTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK FACTOR; SECONDARY PREVENTION; ARTHRITIS, RHEUMATOID; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; COMPLICATION;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; HUMANS; RISK FACTORS;

EID: 84947313265     PISSN: 15216942     EISSN: 15321770     Source Type: Journal    
DOI: 10.1016/j.berh.2015.09.003     Document Type: Review

References (95)

1. J.A. Avina-Zubieta, H.K. Choi, M. Sadatsafavi, and et al. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies Arthritis and Rheumatism 59 12 2008 1690 1697
2. J.A. Avina-Zubieta, J. Thomas, M. Sadatsafavi, and et al. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies Annals of the Rheumatic Diseases 71 9 2012 1524 1529
3. K.P. Liang, E. Myasoedova, C.S. Crowson, and et al. Increased prevalence of diastolic dysfunction in rheumatoid arthritis Annals of the Rheumatic Diseases 69 9 2010 1665 1670
4. P.J. Nicola, H. Maradit-Kremers, V.L. Roger, and et al. The risk of congestive heart failure in rheumatoid arthritis - a population-based study over 46 years Arthritis & Rheumatism 52 2 2005 412 420
5. H. Maradit-Kremers, P.J. Nicola, C.S. Crowson, and et al. Cardiovascular death in rheumatoid arthritis: a population-based study Arthritis and Rheumatism 52 3 2005 722 732
6. A. Gonzalez, H. Maradit Kremers, C.S. Crowson, and et al. The widening mortality gap between rheumatoid arthritis patients and the general population Arthritis and Rheumatism 56 11 2007 3583 3587
7. A.M. Kerola, T.V. Nieminen, L.J. Virta, and et al. No increased cardiovascular mortality among early rheumatoid arthritis patients: a nationwide register study in 2000-2008 Clinical and Experimental Rheumatology 33 3 2015 391 398
8. B.R. England, H. Sayles, K. Michaud, and et al. Cause-specific mortality in US veteran men with rheumatoid arthritis Arthritis Care & Research (Hoboken) Jun 19,2015 10.1002/acr.22642 [Epub ahead of print]
9. C.P. Chung, J.T. Giles, M. Petri, and et al. Prevalence of traditional modifiable cardiovascular risk factors in patients with rheumatoid arthritis: comparison with control subjects from the multi-ethnic study of atherosclerosis Seminars in Arthritis & Rheumatism 41 4 2012 535 544
10. J.J. Lee, and J.E. Pope A meta-analysis of the risk of venous thromboembolism in inflammatory rheumatic diseases Arthritis Research & Therapy 16 5 2014 435
11. A.S. Agatston, W.R. Janowitz, F.J. Hildner, and et al. Quantification of coronary-artery calcium using ultrafast computed-tomography Journal of the American College of Cardiology 15 4 1990 827 832
12. D. Baumgart, A. Schmermund, G. Goerge, and et al. Comparison of electron beam computed tomography with intracoronary ultrasound and coronary angiography for detection of coronary atherosclerosis Journal of the American College of Cardiology 30 1 1997 57 64
13. M.J. Budoff, K. Nasir, R.L. McClelland, and et al. Coronary calcium predicts events better with absolute calcium scores than age-sex-race/ethnicity percentiles: MESA (multi-ethnic study of atherosclerosis) Journal of the American College of Cardiology 53 4 2009 345 352
14. J.T. Giles, M. Szklo, W. Post, and et al. Coronary arterial calcification in rheumatoid arthritis: comparison to the multi-ethnic study of atherosclerosis Arthritis research & Therapy 11 2 2009 R36
15. A.H. Kao, S. Krishnaswami, A. Cunningham, and et al. Subclinical coronary artery calcification and relationship to disease duration in women with rheumatoid arthritis The Journal of Rheumatology 35 1 2008 61 69
16. C.P. Chung, A. Oeser, P. Raggi, and et al. Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors Arthritis and Rheumatism 52 10 2005 3045 3053
17. G.A. Karpouzas, J. Malpeso, T.Y. Choi, and et al. Prevalence, extent and composition of coronary plaque in patients with rheumatoid arthritis without symptoms or prior diagnosis of coronary artery disease Annals of the Rheumatic Diseases 73 10 2014 1797 1804
18. N. Ahmadi, V. Nabavi, F. Hajsadeghi, and et al. Mortality incidence of patients with non-obstructive coronary artery disease diagnosed by computed tomography angiography American Journal of Cardiology 107 1 2011 10 16
19. H.N. Hodis, W.J. Mack, L. LaBree, and et al. The role of carotid arterial intima-media thickness in predicting clinical coronary events Annals of Internal Medicine 128 4 1998 262 269
20. P. Ambrosino, R. Lupoli, A. Di Minno, and et al. Subclinical atherosclerosis in patients with rheumatoid arthritis. A meta-analysis of literature studies Thrombosis and Hemostasis 113 5 2015 916 930
21. M.R. Evans, A. Escalante, D.F. Battafarano, and et al. Carotid atherosclerosis predicts incident acute coronary syndromes in rheumatoid arthritis Arthritis & Rheumatism 63 5 2011 1211 1220
22. I. del Rincon, R.W. Haas, S. Pogosian, and et al. Lower limb arterial incompressibility and obstruction in rheumatoid arthritis Annals of the Rheumatic Diseases 64 3 2005 425 432
23. P.R. Moreno, E. Falk, I.F. Palacios, and et al. Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture Circulation 90 2 1994 775 778
24. R. Virmani, F.D. Kolodgie, A.P. Burke, and et al. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions Arteriosclerosis, Thrombosis, and Vascular Biology 20 5 2000 1262 1275
25. P.K. Shah, E. Falk, J.J. Badimon, and et al. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture Circulation 92 6 1995 1565 1569
26. M.C. Aubry, H. Maradit-Kremers, M.S. Reinalda, and et al. Differences in atherosclerotic coronary heart disease between subjects with and without rheumatoid arthritis The Journal of Rheumatology 34 5 2007 937 942
27. N. Hiari, and J.H. Rudd FDG PET imaging and cardiovascular inflammation Current Cardiology Reports 13 1 2011 43 48
28. K.M. Maki-Petaja, M. Elkhawad, J. Cheriyan, and et al. Anti-tumor necrosis factor-alpha therapy reduces aortic inflammation and stiffness in patients with rheumatoid arthritis Circulation 126 21 2012 2473 2480
29. I.D. del Rincon, K. Williams, M.P. Stern, and et al. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors Arthritis and Rheumatism 44 12 2001 2737 2745
30. I. del Rincon, G.L. Freeman, R.W. Haas, and et al. Relative contribution of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis Arthritis and Rheumatism 52 11 2005 3413 3423
31. L.R. Baghdadi, R.J. Woodman, E.M. Shanahan, and et al. The impact of traditional cardiovascular risk factors on cardiovascular outcomes in patients with rheumatoid arthritis: a systematic review and meta-analysis PLoS One 10 2 2015 e0117952
32. A. Gonzalez, H. Maradit Kremers, C.S. Crowson, and et al. Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients? Annals of the Rheumatic Diseases 67 1 2008 64 69
33. E. Myasoedova, C.S. Crowson, H.M. Kremers, and et al. Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease Annals of the Rheumatic Diseases 70 3 2011 482 487
34. J. Zhang, L. Chen, E. Delzell, and et al. The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis Annals of the Rheumatic Diseases 73 7 2014 1301 1308
35. I. Navarro-Millan, S. Yang, S.L. DuVall, and et al. Association of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: data from the national veterans health administration Annals of the Rheumatic Diseases Jan 21, 2015 pii: annrheumdis-2013-204987. http://dx.doi.org/10.1136/annrheumdis-2013-204987. [Epub ahead of print]
36. K.P. Liao, J. Liu, B. Lu, and et al. The association between lipid levels and major adverse cardiovascular events in rheumatoid arthritis compared to non-RA Arthritis & Rheumatology 67 8 May 2015 2004 2010
37. I. Del Rincon, K. Williams, M.P. Stern, and et al. Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects Arthritis and Rheumatism 48 7 2003 1833 1840
38. I. del Rincon, J.F. Polak, D.H. O'Leary, and et al. Systemic inflammation and cardiovascular risk factors predict rapid progression of atherosclerosis in rheumatoid arthritis Annals of the Rheumatic Diseases 74 6 2015 1118 1123
39. J.T. Giles, W.S. Post, R.S. Blumenthal, and et al. Longitudinal predictors of progression of carotid atherosclerosis in rheumatoid arthritis Arthritis & Rheumatism 63 11 2011 3216 3225
40. S. Kinlay, A.P. Selwyn, P. Libby, and et al. Inflammation, the endothelium, and the acute coronary syndromes Journal of Cardiovascular Pharmacology 32 Suppl. 3 1998 S62 S66
41. H. Ohta, H. Wada, T. Niwa, and et al. Disruption of tumor necrosis factor-alpha gene diminishes the development of atherosclerosis in ApoE-deficient mice Atherosclerosis 180 1 2005 11 17
42. E. Smith, K.M. Prasad, M. Butcher, and et al. Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice Circulation 121 15 2010 1746 1755
43. C.M. Devlin, G. Kuriakose, E. Hirsch, and et al. Genetic alterations of IL-1 receptor antagonist in mice affect plasma cholesterol level and foam cell lesion size Proceedings of the National Academy of Sciences, USA 99 9 2002 6280 6285
44. C.P. Chung, J.T. Giles, R.A. Kronmal, and et al. Progression of coronary artery atherosclerosis in rheumatoid arthritis: comparison with participants from the multi-ethnic study of atherosclerosis Arthritis Research & Therapy 15 5 2013 R134
45. A. Sandoo, N. Chanchlani, J. Hodson, and et al. Classical cardiovascular disease risk factors associate with vascular function and morphology in rheumatoid arthritis: a six-year prospective study Arthritis Research & Therapy 15 6 2013 R203
46. E.E. Arts, J. Fransen, A.A. den Broeder, and et al. The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients Annals of the Rheumatic Diseases 74 6 2015 998 1003
47. M.J. Peters, V.P. van Halm, A.E. Voskuyl, and et al. Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study Arthritis & Rheumatism 61 11 2009 1571 1579
48. C.T. Upchurch, and E.J. Barrett Clinical review: screening for coronary artery disease in type 2 diabetes Journal of Clnical Endocrinology and Metabolism 97 5 2012 1434 1442
49. R.J. Gibbons, G.J. Balady, J.T. Bricker, and et al. ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American college of cardiology/American heart association task force on practice guidelines (committee to update the 1997 exercise testing guidelines) Journal of the American College of Cardiology 40 8 2002 1531 1540
50. D.C. Goff Jr., D.M. Lloyd-Jones, G. Bennett, and et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American college of cardiology/American heart association task force on practice guidelines Circulation 129 2014 S49 S73 (25 Suppl 2)
51. C.S. Crowson, E.L. Matteson, V.L. Roger, and et al. Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis American Journal of Cardiology 110 3 2012 420 424
52. E.E. Arts, C. Popa, A.A. Den Broeder, and et al. Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis Annals of the Rheumatic Diseases 74 4 Apr 2014 668 674
53. M.J. Peters, D.P. Symmons, D. McCarey, and et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis Annals of the Rheumatic Diseases 69 2 2010 325 331
54. N.R. Cook, N.P. Paynter, C.B. Eaton, and et al. Comparison of the Framingham and Reynolds risk scores for global cardiovascular risk prediction in the multiethnic Women's health Initiative Circulation 125 14 2012 1748 1756 S1-11
55. D.H. Solomon, J. Greenberg, J.R. Curtis, and et al. Derivation and internal validation of an expanded cardiovascular risk prediction score for rheumatoid arthritis (ERS-RA): a CORRONA registry study Arthritis & Rheumatology 67 8 May 2015 1995 2003
56. E.E. Arts, C.D. Popa, A.A. Den Broeder, and et al. Prediction of cardiovascular risk in rheumatoid arthritis: performance of original and adapted SCORE algorithms Annals of the Rheumatic Diseases 2015 Feb 17 pii: annrheumdis-2014-206879. http://dx.doi.org/10.1136/annrheumdis-2014-206879. [Epub ahead of print]
57. C. Roubille, V. Richer, T. Starnino, and et al. The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis Annals of the Rheumatic Diseases 74 3 2015 480 489
58. W.G. Dixon, K.D. Watson, M. Lunt, and et al. Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British society for rheumatology biologics register Arthritis & Rheumatism 56 9 2007 2905 2912
59. A. Naranjo, T. Sokka, M.A. Descalzo, and et al. Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study Arthritis Research & Therapy 10 2 2008 R30
60. I. del Rincon, D.F. Battafarano, J.F. Restrepo, and et al. Glucocorticoid dose thresholds associated with all-cause and cardiovascular mortality in rheumatoid arthritis Arthritis & Rheumatology 66 2 2014 264 272
61. V.U. Rao, A. Pavlov, M. Klearman, and et al. An evaluation of risk factors for major adverse cardiovascular events during tocilizumab therapy Arthritis & Rheumatology 67 2 2015 372 380
62. F. Del Porto, B. Lagana, S. Lai, and et al. Response to anti-tumour necrosis factor alpha blockade is associated with reduction of carotid intima-media thickness in patients with active rheumatoid arthritis Rheumatology (Oxford, England) 46 7 2007 1111 1115
63. C. Gonzalez-Juanatey, J. Llorca, C. Garcia-Porrua, and et al. Effect of anti-tumor necrosis factor alpha therapy on the progression of subclinical atherosclerosis in severe rheumatoid arthritis Arthritis & Rheumatism 55 1 2006 150 153
64. R. Dulai, M. Perry, R. Twycross-Lewis, and et al. The effect of tumor necrosis factor-alpha antagonists on arterial stiffness in rheumatoid arthritis: a literature review Seminars in Arthritis & Rheumatism 42 1 2012 1 8
65. A. Ruyssen-Witrand, B. Fautrel, A. Saraux, and et al. Cardiovascular risk induced by low-dose corticosteroids in rheumatoid arthritis: a systematic literature review Joint Bone Spine 78 1 2011 23 30
66. B. Rozman, S. Praprotnik, D. Logar, and et al. Leflunomide and hypertension Annals of the Rheumatic Diseases 61 6 2002 567 569
67. S.K. Penn, A.H. Kao, L.L. Schott, and et al. Hydroxychloroquine and glycemia in women with rheumatoid arthritis and systemic lupus erythematosus Journal of Rheumatology 37 6 2010 1136 1142
68. J.L. Antohe, A. Bili, J.A. Sartorius, and et al. Diabetes mellitus risk in rheumatoid arthritis: reduced incidence with anti-tumor necrosis factor alpha therapy Arthritis Care & Research (Hoboken) 64 2 2012 215 221
69. A. Bili, J.A. Sartorius, H.L. Kirchner, and et al. Hydroxychloroquine use and decreased risk of diabetes in rheumatoid arthritis patients Journal of Clinical Rheumatology 17 3 2011 115 120
70. D.H. Solomon, R. Garg, B. Lu, and et al. Effect of hydroxychloroquine on insulin sensitivity and lipid parameters in rheumatoid arthritis patients without diabetes mellitus: a randomized, blinded crossover trial Arthritis Care & Research (Hoboken) 66 8 2014 1246 1251
71. J.T. Giles, S. Danielides, M. Szklo, and et al. Insulin resistance in rheumatoid arthritis: disease-related indicators and associations with the presence and progression of subclinical atherosclerosis Arthritis & Rheumatology 67 3 2015 626 636
72. K.P. Liao, T. Cai, V.S. Gainer, and et al. Lipid and lipoprotein levels and trend in rheumatoid arthritis compared to the general population Arthritis Care & Research (Hoboken) 65 12 2013 2046 2050
73. E. Myasoedova, C.S. Crowson, H.M. Kremers, and et al. Total cholesterol and LDL levels decrease before rheumatoid arthritis Annals of the Rheumatic Diseases 69 7 2010 1310 1314
74. I. Navarro-Millan, C. Charles-Schoeman, S. Yang, and et al. Changes in lipoproteins associated with methotrexate or combination therapy in early rheumatoid arthritis: results from the treatment of early rheumatoid arthritis trial Arthritis & Rheumatism 65 6 2013 1430 1438
75. I.B. McInnes, L. Thompson, J.T. Giles, and et al. Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study Annals of the Rheumatic Diseases 74 4 2015 694 702
76. C. Charles-Schoeman, R. Fleischmann, J. Davignon, and et al. Potential mechanisms leading to the abnormal lipid profile in patients with rheumatoid arthritis versus healthy volunteers and reversal by tofacitinib Arthritis & Rheumatology 67 3 2015 616 625
77. S. Kinlay Low-density lipoprotein-dependent and -independent effects of cholesterol-lowering therapies on C-reactive protein: a meta-analysis Journal of the American College of Cardiology 49 20 2007 2003 2009
78. D.W. McCarey, I.B. McInnes, R. Madhok, and et al. Trial of Atorvastatin in rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial Lancet 363 9426 2004 2015 2021
79. F. Taylor, M.D. Huffman, A.F. Macedo, and et al. Statins for the primary prevention of cardiovascular disease The Cochrane Database of Systematic Reviews 1 2013 CD004816
80. K. Danninger, U.C. Hoppe, and H. Pieringer Do statins reduce the cardiovascular risk in patients with rheumatoid arthritis? International Journal of Rheumatic Diseases 17 6 2014 606 611
81. M.A. De Vera, H. Choi, M. Abrahamowicz, and et al. Statin discontinuation and risk of acute myocardial infarction in patients with rheumatoid arthritis: a population-based cohort study Annals of the Rheumatic Diseases 70 6 2011 1020 1024
82. E. Myasoedova, S.E. Gabriel, A.B. Green, and et al. Impact of statin use on lipid levels in statin-naive patients with rheumatoid arthritis versus non-rheumatoid arthritis subjects: results from a population-based study Arthritis Care & Research (Hoboken) 65 10 2013 1592 1599
83. A.G. Semb, T.K. Kvien, D.A. DeMicco, and et al. Effect of intensive lipid-lowering therapy on cardiovascular outcome in patients with and those without inflammatory joint disease Arthritis & Rheumatism 64 9 2012 2836 2846
84. N.J. Stone, J.G. Robinson, A.H. Lichtenstein, and et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American college of cardiology/American heart association task force on practice guidelines Journal of the American College of Cardiology 63 25 Pt B 2014 2889 2934
85. G.N. Kitas, P.J. Armitage, N. Sattar, J. Belch, and D. Symmons Trial of atorvastatin for the primary prevention of cardiovascular events in patients with rheumatoid arthritis (TRACE RA) Annals of the Rheumatic Diseases 74 Suppl. 2 2015
86. P.M. Ridker, E. Danielson, F.A. Fonseca, and et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein New England Journal of Medicine 359 21 2008 2195 2207
87. I.B. McInnes, H.Y. Kim, S.H. Lee, and et al. Open-label tofacitinib and double-blind atorvastatin in rheumatoid arthritis patients: a randomised study Annals of the Rheumatic Diseases 73 1 2014 124 131
88. P.B. Lehane, S. Lacey, E.W. Hessey, and et al. Effect of concomitant statins on rituximab efficacy in patients with rheumatoid arthritis Annals of the Rheumatic Diseases 73 10 2014 1906 1908
89. E.E. Arts, T.L. Jansen, A. Den Broeder, and et al. Statins inhibit the antirheumatic effects of rituximab in rheumatoid arthritis: results from the Dutch rheumatoid arthritis monitoring (DREAM) registry Annals of the Rheumatic Diseases 70 5 2011 877 878
90. P.A. James, S. Oparil, B.L. Carter, and et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8) Jama 311 5 2014 507 520
91. J.S. Berger, A. Lala, M.J. Krantz, and et al. Aspirin for the prevention of cardiovascular events in patients without clinical cardiovascular disease: a meta-analysis of randomized trials American Heart Journal 162 1 2011 115-24 e2
92. G.S. Metsios, A. Stavropoulos-Kalinoglou, J.J. Veldhuijzen van Zanten, and et al. Individualised exercise improves endothelial function in patients with rheumatoid arthritis Annals of the Rheumatic Diseases 73 4 2014 748 751
93. A. Stavropoulos-Kalinoglou, G.S. Metsios, J.J. Veldhuijzen van Zanten, and et al. Individualised aerobic and resistance exercise training improves cardiorespiratory fitness and reduces cardiovascular risk in patients with rheumatoid arthritis Annals of the Rheumatic Diseases 72 11 2013 1819 1825
94. J. Lindhardsen, O. Ahlehoff, G.H. Gislason, and et al. Initiation and adherence to secondary prevention pharmacotherapy after myocardial infarction in patients with rheumatoid arthritis: a nationwide cohort study Annals of the Rheumatic Diseases 71 9 2012 1496 1501
95. C.E. Barber, A. Smith, J.M. Esdaile, and et al. Best practices for cardiovascular disease prevention in rheumatoid arthritis: a systematic review of guideline recommendations and quality indicators Arthritis Care & Research (Hoboken) 67 2 2015 169 179